Presentation TCT 2016 Applying Lessons From the CTSN to Clinical Practice Presenter: Michael J. Mack, Francesco Maisano October 30, 2016
Presentation TCT 2016 Assessment and Critical Appraisal of Ongoing RDN Studies: Will the Results Accurately Reflect RDN Effectiveness? Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, Justin E. Davies October 30, 2016
Presentation TCT 2016 Appropriate Use Criteria of LAA Closure Devices: FDAs View Presenter: Mitchell W. Krucoff, Shigeru Saito, Rachel Neubrander October 30, 2016
Presentation TCT 2016 Novel Approaches for Septal Ablation: Beyond Alcohol Presenter: Srihari S. Naidu, Paul Sorajja October 30, 2016
Presentation TCT 2016 Minimally Invasive and Robotic Repair for Primary MR: Less Invasive With Great Outcomes? Presenter: Michael J. Mack, Francesco Maisano, Robert L. Smith October 30, 2016
Presentation TCT 2016 Use of Watchman in Anticoagulant Contraindicated Patients: Has Safety and Efficacy Been Proven? Presenter: Vivek Y. Reddy, Steven J. Yakubov, David R. Holmes Jr. October 30, 2016
Presentation TCT 2016 Alcohol Chemical Neurolysis (Ablative Solutions): Peregrine Results and the Sham-controlled TARGET BP I Trial Presenter: Farrell O. Mendelsohn, Stephen G. Worthley, David E. Kandzari October 30, 2016
Presentation TCT 2016 Bicuspid Aortic Valve Disease: Epidemiology, Anatomy, Classification, and Special Considerations for TAVR Presenter: A. Pieter Kappetein, Allan Schwartz, Lars Sondergaard October 30, 2016
Presentation TCT 2016 Treatment of Renal Artery Fibromuscalar Dysplasia: Indications, Techniques, and Outcomes Presenter: Gary M. Ansel, Michael R. Jaff, Mehdi H. Shishehbor October 30, 2016
Presentation TCT 2016 TCT 515: Prognostic Implications of Instantaneous Wave-Free Ratio (iFR) and Resting Distal-to-Aortic Pressure Ratio (Pd/Pa) Compared with Fractional Flow Reserve (FFR). A 10-Year Follow-Up Study After Deferral of Revascularization Presenter: Michalis Hamilos, Pim A.L. Tonino October 30, 2016